CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- 4 Open-market buy Chief Financial Officer bought 7,300 shares at an average $1.81 ($13,216)
- 4 Open-market buy Chief Commercial Officer bought 50,000 shares at $1.81 ($90,350)
- 4 Open-market buy CHIEF REGULATORY OFFICER bought 50,000 shares at an average $1.79 ($89,740)
- 4 Open-market buy PRESIDENT AND CEO bought 500,000 shares at $1.79 ($893,500)
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale CHIEF MEDICAL OFFICER sold 20,000 shares at $2.50 ($50,024)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy PRESIDENT AND CEO bought 500,000 shares at an average $1.64 ($820,220)
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
Page 5 of 20 · 400 filings